Gene · 9260
Papers4,249
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 4,249
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Growth and Optical Properties of the Whole System of Li(Mn1-x,Nix)PO4 (0 ≤ x ≤ 0.5) Single Crystals. | Materials (Basel) | 2021 | 34885388 | PubTator, text mining | PubMed |
| Multimodality Management of EBV-Associated Nasopharyngeal Carcinoma. | Cancers (Basel) | 2021 | 34885187 | PubTator, text mining | PubMed |
| Proteomic Signatures of Diffuse and Intestinal Subtypes of Gastric Cancer. | Cancers (Basel) | 2021 | 34885041 | PubTator, text mining | PubMed |
| The identification of gene signatures in patients with extranodal NK/T-cell lymphoma from a pair of twins. | BMC Cancer | 2021 | 34872521 | PubTator, text mining | PubMed |
| A heuristic, computer-driven and top-down approach to identify novel bioactive peptides: A proof-of-principle on angiotensin I converting enzyme inhibitory peptides. | Food Res Int | 2021 | 34865771 | PubTator, text mining | PubMed |
| Multiplexed Profiling of Extracellular Vesicles for Biomarker Development. | Nanomicro Lett | 2021 | 34855021 | PubTator, text mining | PubMed |
| TRAIL sensitivity of nasopharyngeal cancer cells involves redox dependent upregulation of TMTC2 and its interaction with membrane caspase-3. | Redox Biol | 2021 | 34839142 | PubTator, text mining | PubMed |
| Paradoxical effects of DNA tumor virus oncogenes on epithelium-derived tumor cell fate during tumor progression and chemotherapy response. | Signal Transduct Target Ther | 2021 | 34836940 | PubTator, text mining | PubMed |
| Prophylactic and Therapeutic EBV Vaccines: Major Scientific Obstacles, Historical Progress, and Future Direction. | Vaccines (Basel) | 2021 | 34835222 | PubTator, text mining | PubMed |
| Dose-Dependent Outcome of EBV Infection of Humanized Mice Based on Green Raji Unit (GRU) Doses. | Viruses | 2021 | 34834989 | PubTator, text mining | PubMed |
| Quantification of EGFR-HER2 Heterodimers in HER2-Overexpressing Breast Cancer Cells Using Liquid-Phase Electron Microscopy. | Cells | 2021 | 34831465 | PubTator, text mining | PubMed |
| Fascin in Gynecological Cancers: An Update of the Literature. | Cancers (Basel) | 2021 | 34830909 | PubTator, text mining | PubMed |
| Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer. | Int J Mol Sci | 2021 | 34830174 | PubTator, text mining | PubMed |
| The association between lncRNA H19 and EZH2 expression in patients with EBV-positive laryngeal carcinoma. | Acta Otorhinolaryngol Ital | 2021 | 34825669 | PubTator, text mining | PubMed |
| Correlation between CD44+ cancer stem cell expression and histopathological types of nasopharyngeal carcinoma. | F1000Res | 2021 | 34804499 | PubTator, text mining | PubMed |
| Progress in Nanomaterials-Based Optical and Electrochemical Methods for the Assays of Exosomes. | Int J Nanomedicine | 2021 | 34803380 | PubTator, text mining | PubMed |
| Adrenergic-Angiogenic Crosstalk in Head and Neck Cancer: Mechanisms and Therapeutic Implications. | Front Oral Health | 2021 | 34790909 | PubTator, text mining | PubMed |
| Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis. | Front Immunol | 2021 | 34790199 | PubTator, text mining | PubMed |
| Correlation of the AKT/mTOR signaling pathway with the clinicopathological features and prognosis of nasopharyngeal carcinoma. | Eur J Histochem | 2021 | 34783234 | PubTator, text mining | PubMed |
| 25-Hydroxycholesterol Inhibits Kaposi's Sarcoma Herpesvirus and Epstein-Barr Virus Infections and Activates Inflammatory Cytokine Responses. | mBio | 2021 | 34781692 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9260/papers?page=38